3 sources checked · 2 source groups included · 39m ago
Still Watching
Appeals court hears bid to curtail access to medication abortion
Philadelphia Inquirer and The Hill describe the same event in different terms.
1 Left2 Center0 Right
Still watching.Optics is waiting for a cleaner match before calling the split.
STILL WATCHING
As of September 9, 2026 at 7:36 PM, this is how Optics News reads the wording differences in this story.
What happenedThe U.S. Supreme Court allowed telehealth access to abortion medication to continue while litigation proceeds.
The headline splitThe left frames it as "An appeals court is considering a push to restrict most common abortion method". The center frames it as "An appeals court is considering a push to restrict most common abortion method".
Match confidenceMedium confidence. 3 sources across 2 bias buckets. Useful framing signal — check the source list before sharing.
Same-event confidenceMedium
3 sources across 2 bias buckets agree on the event.
Framing confidenceModerate
62/99 — meaningful wording shift across the spectrum.
WHAT EACH SIDE EMPHASIZED
Left / center-leftAn appeals court is considering a push to restrict most common abortion method
Philadelphia Inquirer · Center-left · News report
CenterAppeals court hears bid to curtail access to medication abortion
The Hill · Center · News report
Right / center-rightNo matching source in this bucket yet.
Appeals court hears bid to curtail access to medication abortion
A federal appeals court Wednesday heard arguments in a case that could eventually wipe out access to medication abortion, even in blue states that protect abortion. A three-judge panel of t...
An appeals court is considering a push to restrict most common abortion method
A panel of federal judges is considering Louisiana's assertion that mifepristone, a key drug in the most common abortion method in the U.S., should not be dispensed anywhere but a medical f...
An appeals court is considering a push to restrict most common abortion method
A panel of federal judges heard arguments Wednesday over whether prescribing rules should be tightened for a key drug used in the most common abortion method in the United States, one of se...
